Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sigyn Therapeutics, Inc. (RGNP)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Nov-30-16Dec-31-15
   S-1/A10-K10-K10-K10-K10-K10-K/A10-K/A
Net income  -2.9-3.0-1.3-3.1-2.6-4.3-0.6-0.8
Depreciation and amortization   [+]0.00.00.00.10.20.20.10.1
Asset impairment charges   0.5  0.9   
Change in working capital   [+]0.30.00.10.10.40.50.40.1
Other operating activities  0.80.70.32.80.83.20.00.0
Cash from operations  -1.8-1.8-0.8-0.1-0.3-0.4-0.1-0.6
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Purchases of intangible assets      0.0-0.1-0.1-0.1
Other cash from investing    0.00.1  0.00.0
Cash from investing  0.00.00.00.10.0-0.1-0.1-0.1
   
Other cash from financing  1.52.10.90.00.30.30.20.4
Cash from financing  1.52.10.90.00.30.30.20.4
   
Free cash flow  -1.8-1.8-0.8-0.1-0.3-0.4-0.1-0.6
        Per share (diluted)  ($0.05)($0.05)($0.11)$0.00$0.00($0.01)($0.01)($0.06)
   
Cash paid for income taxes       0.0  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy